Showing results (141-150 of 233) with videos related to
Sort By:
Pageof 24
Research and Practice in Thrombosis and Haemostasis|September 2, 2024
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpuraKaterina Pavenski, Marie Scully, Paul Coppo, et al.Frontiers in Immunology|July 10, 2024
A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITLLaure Ricard, Pascale Cervera, Nicolas Stocker, et al.Haematologica|November 2, 2020
Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpuraNuno A G Graça, Bogac Ercig, Leydi Carolina Velásquez Pereira, et al.Kidney International Reports|April 14, 2025
Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal CrisisAïcha Kante, Paul Legendre, Bérangère S Joly, et al.The Lancet. Haematology|October 11, 2016
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathyBérangère S Joly, Alain Stepanian, Thierry Leblanc, et al.Journal of Nephrology|October 10, 2023
The challenging follow-up of pregnancy in women with known thrombotic thrombocytopenic purpura: a single-center experience of a preemptive management protocolAghiles Hamroun, Camille Prouteau, Rémi Lenain, et al.Scandinavian Journal of Immunology|December 8, 2021
Overexpression of IgG2 in patients resembling IgG4-related disease with normal IgG4Mathilde Lecuit, Pierre Aucouturier, Aicha Abbas, et al.Blood Advances|September 24, 2021
Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTPLaure De Waele, Alexandre Curie, Kadri Kangro, et al.Blood Advances|April 21, 2021
Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysisFlora Peyvandi, Spero Cataland, Marie Scully, et al.Haematologica|December 1, 2022
Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severityEdwige Tellier, Agnès Widemann, Raphaël Cauchois, et al.Pageof 24